97 related articles for article (PubMed ID: 20618734)
1. Lymphohistiocytoid mesothelioma of the pleura.
Kawai T; Hiroi S; Nakanishi K; Takagawa K; Haba R; Hayashi K; Kawachi K; Nozawa A; Hebisawa A; Nakatani Y
Pathol Int; 2010 Aug; 60(8):566-74. PubMed ID: 20618734
[TBL] [Abstract][Full Text] [Related]
2. Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases.
Galateau-Sallé F; Attanoos R; Gibbs AR; Burke L; Astoul P; Rolland P; Ilg AG; Pairon JC; Brochard P; Begueret H; Vignaud JM; Kerr K; Launoy G; Imbernon E; Goldberg M
Am J Surg Pathol; 2007 May; 31(5):711-6. PubMed ID: 17460454
[TBL] [Abstract][Full Text] [Related]
3. Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review.
Yao DX; Shia J; Erlandson RA; Klimstra DS
Ultrastruct Pathol; 2004; 28(4):213-28. PubMed ID: 15693633
[TBL] [Abstract][Full Text] [Related]
4. 9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis.
Takeda M; Kasai T; Enomoto Y; Takano M; Morita K; Kadota E; Nonomura A
Pathol Int; 2010 May; 60(5):395-9. PubMed ID: 20518890
[TBL] [Abstract][Full Text] [Related]
5. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T
Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849
[TBL] [Abstract][Full Text] [Related]
6. Malignant pleural mesothelioma: clinicopathology of 16 extrapleural pneumonectomy patients with special reference to early stage features.
Hiroshima K; Yusa T; Kameya T; Ito I; Kaneko K; Kadoyama C; Kishi H; Saitoh Y; Ozaki D; Itami M; Iwata T; Iyoda A; Kawai T; Yoshino I; Nakatani Y
Pathol Int; 2009 Aug; 59(8):537-45. PubMed ID: 19627537
[TBL] [Abstract][Full Text] [Related]
7. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M
Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584
[TBL] [Abstract][Full Text] [Related]
8. Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma.
Khalidi HS; Medeiros LJ; Battifora H
Am J Clin Pathol; 2000 May; 113(5):649-54. PubMed ID: 10800396
[TBL] [Abstract][Full Text] [Related]
9. Lymphohistiocytoid mesothelioma of the pleura: a case report with cytological findings.
Tresserra F; Castella M; Fabra G; Angeles Martinez M; Dominguez M; Fernandez-Cid C; Amalrich MD; Ramos C
Diagn Cytopathol; 2013 Jun; 41(6):546-9. PubMed ID: 22021116
[TBL] [Abstract][Full Text] [Related]
10. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
[TBL] [Abstract][Full Text] [Related]
11. Well-differentiated papillary mesothelioma with invasion to the chest wall.
Torii I; Hashimoto M; Terada T; Kondo N; Fushimi H; Shimazu K; Takeda S; Takuwa T; Okumura Y; Sato A; Yamamoto T; Fukuoka K; Tanaka F; Nishigami T; Nakano T; Hasegawa S; Tsujimura T
Lung Cancer; 2010 Feb; 67(2):244-7. PubMed ID: 19880210
[TBL] [Abstract][Full Text] [Related]
12. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
[TBL] [Abstract][Full Text] [Related]
13. [Small-cell mesothelioma of the pleura: description of a case].
Cavazza A; Rossi G; Agostini L; Facciolongo N; De Marco L; Putrino I; Gardini G
Pathologica; 2002 Oct; 94(5):247-52. PubMed ID: 12417972
[TBL] [Abstract][Full Text] [Related]
14. [Sarcomatoid mesothelioma--a diagnostic challenge].
Eiholm S; Meyer CN; Behrendt N
Ugeskr Laeger; 2010 Sep; 172(39):2670-1. PubMed ID: 20920392
[TBL] [Abstract][Full Text] [Related]
15. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
16. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
[TBL] [Abstract][Full Text] [Related]
17. The alpha folate receptor is highly activated in malignant pleural mesothelioma.
Bueno R; Appasani K; Mercer H; Lester S; Sugarbaker D
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):225-33. PubMed ID: 11174727
[TBL] [Abstract][Full Text] [Related]
18. [Malignant mesothelioma of the pleura among women].
Bianchi C; Bianchi T; Ramani L
Med Lav; 2004; 95(5):376-80. PubMed ID: 15595200
[TBL] [Abstract][Full Text] [Related]
19. Case reports of primary pulmonary adenocarcinoma with pleural spread: so-called pseudomesotheliomatous adenocarcinoma.
Saito R; Kasajima A; Taniuchi S; Fujishima F; Ishida K; Nakamura Y; Yamanda S; Takahashi T; Hitomi H; Murakami K; Watanabe M; Sasano H
Pathol Int; 2012 Oct; 62(10):709-15. PubMed ID: 23005599
[TBL] [Abstract][Full Text] [Related]
20. Ten cases of feline mesothelioma: an immunohistochemical and ultrastructural study.
Bacci B; Morandi F; De Meo M; Marcato PS
J Comp Pathol; 2006 May; 134(4):347-54. PubMed ID: 16712862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
